Single answer
Is Acurx Pharmaceuticals Inc (ACXP) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Acurx Pharmaceuticals Inc a clinical stage biopharmaceutical company develops antibiotics to treat bacterial infections Its lead antibiotic candidate is ibezapolstat a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections The company is also developing ACX375C a potential oral and parenteral treatment targeting grampositive bacteria including methicillinresistant staphylococcus aureus vancomycinresistant enterococcus and penicillinresistant streptococcus pneumoniae Acurx Pharmaceuticals Inc was incorporated in 2017 and is headquartered in Staten Island New York
Website: https://www.acurxpharma.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.00. Cash flow to debt ratio: 0.00. Net profit margin: 0.00%. Inflation risk score: medium (0.60/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Acurx Pharmaceuticals Inc is $2.6M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Acurx Pharmaceuticals Inc 10 years ago, but if you had invested on 2021-06-25 when the price was $7.89, you would have made a loss of $6.34 per share or 80.35%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.